Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C-Reference-Cited by-同舟云学术

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Published:2018-04 Issue:4 Volume:68 Page:663-671
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Buggisch Peter,Vermehren Johannes,Mauss Stefan,Günther Rainer,Schott Eckart,Pathil Anita,Boeker Klaus,Zimmermann Tim,Teuber Gerlinde,Vornkahl Heike-Pfeiffer,Simon Karl-Georg,Niederau Claus,Wedemeyer Heiner,Zeuzem Stefan

Publisher

Elsevier BV

Subject

Hepatology

Reference17 articles.

1. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

2. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

3. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis;Kowdley;N Engl J Med,2014

4. EASL recommendations on treatment of hepatitis C 2015;J Hepatol,2015

5. No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mL;O'Brien;Hepatology,2016

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C;Journal of Infection;2024-11

2. Real-World Data on the Use of Glecaprevir/Pibrentasvir in the Treatment of Hepatitis C: Is Shorter Treatment Possible?;Viral Hepatitis Journal;2024-08-28

3. Prognosis Following Sustained Virologic Response in Korean Chronic Hepatitis C Patients Treated with Sofosbuvir-Based Treatment: Data from a Multicenter Prospective Observational Study up to 7 Years;Medicina;2024-07-14

4. Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis;Swiss Medical Weekly;2024-06-24

5. Virological characterization of treatment failures and retreatment outcomes in patients infected with “unusual” HCV genotype 1 subtypes;Hepatology;2023-04-01